Pacira | PCRX - Przychody Ze Sprzedaży





Obroty Zmiana Data
Astellas Pharma JPY 640.91B 102.98B 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
J&J USD 25.31B 1.21B 2026-06
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novo Nordisk DKK 78.49B 18.33B 2026-06
Pacira USD 192.4M 15.4M 2026-06
Perrigo USD 1.02B 51M 2026-06
Pfizer USD 15.03B 530M 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Zoetis USD 2.5B 200M 2026-06